Navigation Links
Ceregene Phase 2 Clinical Trial for Alzheimer's Disease to be Funded by $5.4 Million Grant From National Institutes of Health
Date:11/4/2008

ved in Alzheimer's disease.

About Alzheimer's Disease

Alzheimer's disease is a progressive disorder of the brain that gradually affects one's memory and ability to learn, reason, communicate and carry out daily activities. There are now more than five million people in the United States living with Alzheimer's disease, and there is currently no cure.

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of nervous system growth factors for the treatment of neurodegenerative disorders using gene delivery. Ceregene's clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor that is currently in Phase 1 studies for the treatment of Alzheimer's disease, and CERE-120 (AAV2-Neurturin) which has completed enrollment of a controlled Phase 2 study for Parkinson's disease. CERE-135 and CERE-140 are in preclinical development for ALS (Lou Gehrig's disease) and ocular disorders, respectively. Ceregene was launched in January 2001. The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, Inc. (Nasdaq: CEGE) as well as Hamilton BioVentures and California Technology Partners.


'/>"/>
SOURCE Ceregene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinsons Disease
2. Derma Sciences Enrolls First Patient in DSC127 Phase II Study
3. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
4. Phase 2a Data for MEDI-528 Presented at CHEST 2008
5. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
6. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
7. QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
8. Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
9. Teksouth Awarded $100,000 Defense Department Grant in First Phase of Medical Data Integration Project
10. Assessing the quality of phase I clinical trial abstracts
11. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... You've probably heard that using cotton swabs to ... have you found a better way to remove ear wax? ... what you need. , They developed SUNDENG EAR CLEANER to ... dry skin from the ears. What's more, it is safer ... the market today for children and adults of all ages. ...
(Date:5/30/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 30, ... quick, safe, and simple procedure to lighten or stop ... the risks of hysterectomy. This procedure can reduce or ... or the lining of the uterus (the part that ... energy. , About 10 million women suffer from heavy ...
(Date:5/30/2015)... 2015 On Thursday, May 14, ... Simone and Dr. Evan Alley both of the ... Mesothelioma Experts’ series. The interview was part of ... of excellence. Drs. Simone and Alley were interviewed ... with whom they discussed the mesothelioma program at ...
(Date:5/30/2015)... EHO offers a suite of online ... hospices the ability to manage their drug-spend for the ... model, EHO has been able to compete with the ... and survive among the giants of the industry. Since ... years ago, it has simplified the way hospices can ...
(Date:5/30/2015)... ROTHWELL, Australia (PRWEB) May 30, 2015 At ... the rewards of vibrant health , which she attributes ... personally tested principles of good nutrition with the release of ... ” (published by Xlibris AU). , “Cook for Health and ... using natural, nutritious and mostly organic food . It ...
Breaking Medicine News(10 mins):Health News:Improved Ear Hygiene Tool Invented by InventHelp Clients (KSC-952) 2Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3
... SEATTLE Larry Corey, M.D., president and director of Fred ... the American Academy of Arts and Sciences, one of the ... centers. , "I,m extremely honored to be in the same ... science, medicine and the arts," Corey said. "I,m also very ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) ... through talk therapy and medication. But for some, severe ... turn to brain surgery, and a new study shows ... patients who underwent "stereotactic anterior cingulotomy" at Massachusetts General ...
... (Avastin) to the standard chemotherapy regimen for non-small cell lung ... 2006 did not lead to significantly increase survival rates ... a new study by Dana-Farber Cancer Institute researchers has found. ... Journal of the American Medical Association , a these ...
... Regenstrief Institute investigator Christopher Callahan, M.D., Cornelius and Yvonne ... of Medicine and director of the IU Center for ... Career Achievement and Contribution to Clinical and Translational Science ... D.C., April 18 to 20. Dr. Callahan, who ...
... 16, 2012 Wake Forest Baptist Medical Center researchers seeking a ... size and extent of damaged tissue can be reduced by ... The research, the focus of a three-year, $1.5 million study ... the journal Neurosurgery . The technology, tested in ...
... undergoing chemoradiation therapy (CRT) for head and neck cancer, ... short-term improvement in swallowing function; however, there were no ... and controls at nine or 12 months following treatment, ... Archives of Otolaryngology Head & Neck Surgery ...
Cached Medicine News:Health News:Hutchinson Center president elected to American Academy of Art and Sciences 2Health News:Hutchinson Center president elected to American Academy of Art and Sciences 3Health News:Brain Surgery Might Ease Tough-to-Treat OCD 2Health News:Brain Surgery Might Ease Tough-to-Treat OCD 3Health News:Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients 2Health News:Callahan honored for improving older adults' health in their doctors' offices 2Health News:Mechanical tissue resuscitation technology shows promise 2Health News:Swallowing exercises linked with short-term improvement among patients with head and neck cancer 2
(Date:5/29/2015)... 29, 2015 A six-hour certification program on ... at the Cannabis World Congress & Business Exposition ... NY .  Taking place on Wednesday, June 17 th ... education at the leading event on the East Coast for ... by Clover Leaf University, the first cannabis university to be ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. Drug delivery ... to other systems because of the anatomy and ... and nutrients to all organs of the body. ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/ltwldz/surgicaloperating ... "Surgical/Operating Microscopes Market by Application & End User ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... to reach $806.6 million by 2020 from $402.2 ... from 2015 to 2020. , ,Major factors fueling ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... penicillin , , , ... June 17 The U.S. Food and Drug Administration today warned consumers ... tests revealed that the fraudulent product does not contain Tamiflu,s active ingredient, oseltamivir, but ... , , ...
... , PITTSBURGH , June 17 Mylan ... Mylan Pharmaceuticals Inc. received final approval from the U.S. Food ... (ANDA) for Hydroxyzine Hydrochloride Tablets 10 mg, 25 mg and ... therefore, therapeutically equivalent to Pliva,s Hydroxyzine Hydrochloride Tablets, a treatment ...
Cached Medicine Technology:FDA Warns About Fraudulent Tamiflu 2FDA Warns About Fraudulent Tamiflu 3Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets 2
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
Coaxial fiberoptic headlight has fixed spot size of 120mm. It weighs only 4.5 ounces....
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband....
Medicine Products: